Japan approves Alzheimer's drug developed by Eisai, Biogen

Japan's health ministry on Monday approved the manufacture and sale of a drug for Alzheimer's developed by Japanese pharmaceutical company Eisai Co and U.S. firm Biogen Inc.

Lecanemab,…